Renato Gomes, Jean-Marie Lozachmeur, and Lucas Maestri, “Nonlinear Pricing in Oligopoly: How Brand Preferences Shape Market Outcomes”, TSE Working Paper, n. 22-1326, March 2022.
Pham Hoang Uyen, Vo Thi Le Uyen, Pham Van Chung, Stéphane Cezera, and Manh-Hung Nguyen, “Covid-19 Pandemic and Performance of Economic Sectors in Vietnam”, TSE Working Paper, n. 22-1304, February 2022.
Pierre Dubois, Rachel Griffith, and Martin O'Connell, “The Use of Scanner Data for Economics Research”, TSE Working Paper, n. 22-1286, January 2022, revised March 2022.
Philippe De Donder, Humberto Llavador, Stefan Penczynski, John E. Roemer, and Roberto Vélez, “Nash versus Kant: A game-theoretic analysis of childhood vaccination behavior”, TSE Working Paper, n. 21-1278, December 2021, revised 2025.
Philippe De Donder, Bertrand Achou, Franca Glenzer, Minjoon Lee, and Marie-Louise Leroux, “Nursing home aversion post-pandemic: Implications for savings and long-term care policy”, TSE Working Paper, n. 21-1249, September 2021.
Catarina Goulão, and Agustín Pérez-Barahona, “Health aspirations and the epidemic of non-communicable chronic diseases”, TSE Working Paper, n. 21-1236, July 2021, revised June 2023.
David Bardey, Arturo Harker, and Daniela Zuluaga, “Price cap regulation in the Colombian pharmaceutical market: An impact evaluation”, TSE Working Paper, n. 21-1195, March 2021.
David Bardey, Manuel Fernandez, and Alexis Gravel, “Coronavirus and Social Distancing: Do Non-Pharmaceutical-Interventions Work (at least) in the Short Run?”, TSE Working Paper, n. 21-1189, February 2021.
James K. Hammitt, and Nicolas Treich, “Fatality Risk Regulation”, TSE Working Paper, n. 21-1177, January 2021.
James K. Hammitt, “Valuing mortality risk in the time of covid-19”, TSE Working Paper, n. 20-1115, June 2020.